Soluble Interleukin-2 Receptor: A Potential Marker for Monitoring Disease Activity in IgG4-Related Disease.

Faiz KarimL E M EurelingsR D BansieP M van HagenJ A M van LaarW A Dik

Published in: Mediators of inflammation (2018)

Serum sIL-2R is elevated in IgG4-RD reflecting the inflammatory process with enhanced T-cell activation. Furthermore, serum sIL-2R might serve as a potential marker of response to treatment in IgG4-RD.

Keyphrases

disease activity
rheumatoid arthritis
systemic lupus erythematosus
rheumatoid arthritis patients
ankylosing spondylitis
juvenile idiopathic arthritis
oxidative stress
risk assessment
climate change
replacement therapy